Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Hialeah › NPI 1013382860
Hospital

Larkin Community Hospital Palm Springs Campus, LLC

Larkin Community Hospital Palm Springs Campus, LLC was paid $1.89M by Medicaid between Jan 2018 and Apr 2023, across 117 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 14% of everything it billed.

33Billing provider infoLARKIN COMMUNITY HOSPITAL PALM SPRINGS CAMPUS, LLC
HIALEAH, FL 33012
33aNPI1013382860assigned 12/04/2015
28Total paid$1.89M
24GClaims154,848
24DCodes billed117
24AFirst – last monthJan 2018 – Apr 2023
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#122 of 163
Median peer was paid$4.77M
This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201826,983$292K
201960,246$420K
202022,056$281K
202120,161$266K
202219,615$480K
20235,787$148K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
74176 Computed tomography, abdomen and pelvis; without contrast material 14% 1,777 1,356 $263K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 4,757 3,737 $222K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.2% 5,829 4,221 $173K
70450 Computed tomography, head or brain; without contrast material 7.2% 2,289 1,650 $135K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 6.9% 3,843 2,628 $130K
81003 5.2% 2,703 1,986 $98K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 5.0% 4,730 3,502 $94K
G0378 Hospital observation service, per hour 3.8% 4,578 2,704 $71K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.6% 2,099 1,344 $68K
80048 Basic metabolic panel (calcium, ionized) 3.5% 7,982 4,174 $67K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 3.3% 1,381 1,143 $62K
82962 2.4% 4,213 1,430 $45K
105 more codes
96368 2.3% 2,664 $43K
80053 Comprehensive metabolic panel 1.6% 5,360 $30K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.4% 13,183 $27K
84484 1.2% 6,231 $23K
J7050 Infusion, normal saline solution, 250 cc 1.2% 3,024 $22K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.1% 2,241 $21K
71045 Radiologic examination, chest; single view <1% 6,557 $18K
80076 <1% 2,486 $18K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,607 $17K
36415 Collection of venous blood by venipuncture <1% 6,672 $16K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,104 $15K
93041 <1% 6,499 $15K
83690 <1% 2,442 $15K
85610 <1% 3,977 $13K
85730 <1% 3,964 $13K
81000 <1% 1,902 $10K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 630 $10K
82150 <1% 1,434 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,578 $9K
87040 <1% 2,171 $7K
82550 <1% 2,061 $7K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 151 $7K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,391 $7K
83880 <1% 1,251 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,135 $5K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,736 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 513 $5K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 186 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,370 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 282 $4K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 1,289 $4K
84703 <1% 1,133 $4K
87070 <1% 354 $3K
82803 <1% 503 $3K
84443 Thyroid stimulating hormone (TSH) <1% 1,756 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 1,046 $3K
96361 Intravenous infusion, hydration; each additional hour <1% 171 $3K
94664 <1% 370 $2K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 313 $2K
83605 <1% 1,448 $2K
87186 <1% 423 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,546 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 493 $1K
86141 <1% 41 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 632 $1K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 210 $1K
81001 <1% 1,958 $1K
93970 <1% 106 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 31 $1K
96367 <1% 103 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 46 $993.77
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 27 $739.33
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 96 $718.64
80061 Lipid panel <1% 616 $658.09
72131 <1% 65 $617.88
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 49 $601.82
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 36 $589.81
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 121 $580.40
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 15 $558.15
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 72 $448.36
85379 <1% 445 $432.86
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 16 $430.33
86900 <1% 18 $375.97
72170 <1% 154 $348.90
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 240 $313.10
J2270 Injection, morphine sulfate, up to 10 mg <1% 57 $271.94
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 299 $254.07
87205 <1% 634 $225.03
93880 <1% 24 $202.98
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 186 $185.28
71250 <1% 44 $173.88
82607 <1% 57 $164.36
J0735 Injection, clonidine hydrochloride, 1 mg <1% 224 $162.53
83735 <1% 580 $154.70
86769 <1% 1,311 $133.67
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 127 $119.83
71046 Radiologic examination, chest; 2 views <1% 32 $111.70
85652 <1% 81 $100.51
J2060 Injection, lorazepam, 2 mg <1% 105 $88.43
76770 <1% 18 $52.38
83036 Hemoglobin; glycosylated (A1C) <1% 171 $29.27
82553 <1% 169 $12.36
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 817 $11.88
82746 <1% 18 $11.86
84436 <1% 141 $11.86
86850 <1% 37 $8.86
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 41 $7.02
82947 <1% 164 $3.13
87081 <1% 433 $2.69
82570 <1% 38 $1.56
83615 0% 39 $0.00
88342 0% 157 $0.00
80320 0% 26 $0.00
J0456 Injection, azithromycin, 500 mg 0% 54 $0.00
86738 0% 19 $0.00
86403 0% 42 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 133 $0.00
82728 0% 39 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 0% 232 $0.00
84100 0% 51 $0.00
82805 0% 19 $0.00
72125 Computed tomography, cervical spine; without contrast material 0% 51 $0.00
81025 0% 146 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 84 $0.00
83540 0% 23 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSOSA-GUERRERO, SANDRA (CEO)